-
1
-
-
73249149518
-
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?
-
DE Singer, Y Chang, MC Fang et al. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation? Circ Cardiovasc Qual Outcomes 2 2009 297 304
-
(2009)
Circ Cardiovasc Qual Outcomes
, vol.2
, pp. 297-304
-
-
Singer, D.E.1
Chang, Y.2
Fang, M.C.3
-
2
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
for the RE-LY Steering Committee and Investigators
-
SJ Connolly, MD Ezekowitz, S Yusuf for the RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
-
3
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
for the ROCKET AF Steering Committee and Investigators
-
MR Patel, KW Mahaffey, J Garg for the ROCKET AF Steering Committee and Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
-
4
-
-
84856387132
-
Self-monitoring of oral anticoagulation: Systematic review and meta-analysis of individual patient data
-
The Self-Monitoring Trialist Collaboration 10.1016/S0140-6736(11)61294-4 published online Dec 1
-
C Heneghan, A Ward, R Perera The Self-Monitoring Trialist Collaboration Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data Lancet 2011 10.1016/S0140-6736(11)61294-4 published online Dec 1.
-
(2011)
Lancet
-
-
Heneghan, C.1
Ward, A.2
Perera, R.3
-
5
-
-
79955432126
-
Meta-analysis: Effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes
-
HE Bloomfield, A Krause, N Greer et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes Ann Intern Med 154 2011 472 482
-
(2011)
Ann Intern Med
, vol.154
, pp. 472-482
-
-
Bloomfield, H.E.1
Krause, A.2
Greer, N.3
-
6
-
-
71849117615
-
Dabigatran versus warfarin in the treatment of acute venous thromboembolism
-
for the RE-COVER Study Group
-
S Schulman, C Kearon, AK Kakkar for the RE-COVER Study Group Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
-
(2009)
N Engl J Med
, vol.361
, pp. 2342-2352
-
-
Schulman, S.1
Kearon, C.2
Kakkar, A.K.3
-
7
-
-
78650619315
-
Oral rivaroxaban for symptomatic venous thromboembolism
-
The EINSTEIN Investigators
-
The EINSTEIN Investigators Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
-
(2010)
N Engl J Med
, vol.363
, pp. 2499-2510
-
-
-
8
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
for the ARISTOTLE Committees and Investigators
-
CB Granger, JH Alexander, JJ McMurray for the ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
-
9
-
-
77956977472
-
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial
-
for the RE-LY investigators
-
L Wallentin, S Yusuf, MD Ezekowitz for the RE-LY investigators Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Lancet 376 2010 975 983
-
(2010)
Lancet
, vol.376
, pp. 975-983
-
-
Wallentin, L.1
Yusuf, S.2
Ezekowitz, M.D.3
|
